{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:23:08Z","timestamp":1787502188218,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ijom.2016.10.009","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T10:16:16Z","timestamp":1479550576000},"page":"151-156","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy of the C-terminal telopeptide test in predicting the development of bisphosphonate-related osteonecrosis of the jaw: a systematic review"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-7011","authenticated-orcid":false,"given":"K.J.","family":"Dal Pr\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.A.","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.P.","family":"Soubhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.P.","family":"Pellizzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2016.10.009_bib0195","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.10.009_bib0200","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijom.2016.10.009_bib0205","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.10.009_bib0210","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","article-title":"Pathophysiology of osteonecrosis of the jaws","volume":"27","author":"Aghaloo","year":"2015","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.ijom.2016.10.009_bib0215","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","article-title":"Osteonecrosis of the jaw: who gets it, and why?","volume":"44","author":"Reid","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.ijom.2016.10.009_bib0220","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cid.12297","article-title":"Biomarkers for bisphosphonate-related osteonecrosis of the jaw","volume":"18","author":"Kim","year":"2016","journal-title":"Clin Implant Dent Relat Res"},{"key":"10.1016\/j.ijom.2016.10.009_bib0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cden.2007.09.002","article-title":"Biophosphonate-related osteonecrosis of the jaws","volume":"52","author":"Ruggiero","year":"2008","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.ijom.2016.10.009_bib0230","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/SPC.0b013e32833d303b","article-title":"Updates on osteonecrosis of the jaw","volume":"4","author":"Yamashita","year":"2010","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.ijom.2016.10.009_bib0235","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.10.009_bib0240","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.joms.2009.07.088","article-title":"CTX and its role in managing patients exposed to oral bisphosphonates","volume":"68","author":"Dodson","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.10.009_bib0245","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/ID.0b013e3181c6837c","article-title":"CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part I: biological concepts with a review of the literature","volume":"18","author":"Lee","year":"2009","journal-title":"Implant Dent"},{"key":"10.1016\/j.ijom.2016.10.009_bib0250","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.joms.2009.04.067","article-title":"Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Kwon","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.10.009_bib0255","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0501.2010.01965.x","article-title":"Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers?","volume":"22","author":"Kwon","year":"2011","journal-title":"Clin Oral Implants Res"},{"key":"10.1016\/j.ijom.2016.10.009_bib0260","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.joms.2014.02.036","article-title":"A C-terminal crosslinking telopeptide test-based protocol for patients on oral bisphosphonates requiring extraction: a prospective single-center controlled study","volume":"72","author":"Hutcheson","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.10.009_bib0265","doi-asserted-by":"crossref","first-page":"406","DOI":"10.14219\/jada.archive.2013.0134","article-title":"Assessing the association between bisphosphonate exposure and delayed mucosal healing after tooth extraction","volume":"144","author":"Migliorati","year":"2013","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.ijom.2016.10.009_bib0270","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11845-011-0790-5","article-title":"A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery?","volume":"181","author":"O\u2019Connell","year":"2012","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.ijom.2016.10.009_bib0275","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijom.2016.10.009_bib0280","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.prosdent.2015.08.026","article-title":"Evaluation of cement-retained versus screw-retained implant-supported restorations for marginal bone loss: a systematic review and meta-analysis","volume":"115","author":"Lemos","year":"2016","journal-title":"J Prosthet Dent"},{"key":"10.1016\/j.ijom.2016.10.009_bib0285","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijom.2015.07.012","article-title":"Effects of platelet-rich plasma in association with bone grafts in maxillary sinus augmentation: a systematic review and meta-analysis","volume":"45","author":"Lemos","year":"2016","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.10.009_bib0290","series-title":"NHMRC additional levels of evidence and grades for recommendations for developers of guidelines","author":"Coleman","year":"2009"},{"key":"10.1016\/j.ijom.2016.10.009_bib0295","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.ijom.2016.10.009_bib0300","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bone.2013.08.005","article-title":"Prospective biomarker evaluation in patients with osteonecrosis of the jaw who received bisphosphonates","volume":"57","author":"Kim","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.ijom.2016.10.009_bib0305","first-page":"819","article-title":"Evaluation of serum biomarkers IL-17 and CTX for BRONJ: a pilot clinical case\u2013control study","volume":"41","author":"Lee","year":"2013","journal-title":"J Calif Dent Assoc"},{"key":"10.1016\/j.ijom.2016.10.009_bib0310","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tripleo.2010.04.023","article-title":"Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers","volume":"110","author":"Fleisher","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ijom.2016.10.009_bib0315","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.4317\/medoral.17583","article-title":"Study of serum CTX in 50 oral surgical patients treated with oral bisphosphonates","volume":"17","author":"Flichy-Fern\u00e1ndez","year":"2012","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.ijom.2016.10.009_bib0320","first-page":"31","article-title":"Surgical protocol in patients at risk for bisphosphonate osteonecrosis of the jaws: clinical use of serum telopeptide CTX in preventive monitoring of surgical risk","volume":"3","author":"Carini","year":"2012","journal-title":"Ann Stomatol (Roma)"},{"key":"10.1016\/j.ijom.2016.10.009_bib0325","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.joms.2010.05.043","article-title":"Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates","volume":"68","author":"Lazarovici","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.10.009_bib0330","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/ID.0b013e3181cec8bc","article-title":"CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study","volume":"19","author":"Lee","year":"2010","journal-title":"Implant Dent"},{"key":"10.1016\/j.ijom.2016.10.009_bib0335","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.joms.2009.02.004","article-title":"Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws","volume":"67","author":"Kunchur","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.10.009_bib0340","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.4317\/jced.50698","article-title":"Bone necrosis around dental implants: a patient treated with oral bisphosphonates, drug holiday and no risk according to serum CTX","volume":"4","author":"Flichy-Fern\u00e1ndez","year":"2012","journal-title":"J Clin Exp Dent"},{"key":"10.1016\/j.ijom.2016.10.009_bib0345","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.joms.2015.03.015","article-title":"High C-terminal cross-linking telopeptide levels are associated with a minimal risk of osteonecrosis of the jaws in patients taking oral bisphosphonates and having exodontia","volume":"73","author":"Friedlander","year":"2015","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.10.009_bib0350","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.4317\/medoral.18076","article-title":"Bisphosphonate-related osteonecrosis of the jaws (BRONJ)","volume":"18","author":"Beninati","year":"2013","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.ijom.2016.10.009_bib0355","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40780-015-0035-2","article-title":"Analysis of the time-to-onset of osteonecrosis of jaw with bisphosphonate treatment using the data from a spontaneous reporting system of adverse drug events","volume":"1","author":"Nakamura","year":"2015","journal-title":"J Pharm Health Care Sci"},{"key":"10.1016\/j.ijom.2016.10.009_bib0360","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ijom.2016.10.009_bib0365","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.coms.2015.06.003","article-title":"The frequency of medication-related osteonecrosis of the jaw and its associated risk factors","volume":"27","author":"Dodson","year":"2015","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.ijom.2016.10.009_bib0370","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.oraloncology.2008.01.012","article-title":"Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates","volume":"44","author":"Bagan","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijom.2016.10.009_bib0375","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40618-014-0152-z","article-title":"Treatment of post-menopausal osteoporosis: beyond bisphosphonates","volume":"38","author":"Ishtiaq","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ijom.2016.10.009_bib0380","first-page":"121","article-title":"Postmenopausal osteoporosis\u2014clinical, biological and histopathological aspects","volume":"57","author":"Pavel","year":"2016","journal-title":"Rom J Morphol Embryol"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S090150271630282X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S090150271630282X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T10:58:46Z","timestamp":1536231526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S090150271630282X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S090150271630282X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2016.10.009","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}